ICONE: An International Consortium of Neuro Endovascular Centres

Jean Raymond, P. White, David F Kallmes, J. Spears, T. Marotta, D. Roy, F. Guilbert, A. Weill, T. Nguyen, A. J. Molyneux, H. Cloft, S. Cekirge, I. Saatci, S. Bracard, J. F. Meder, J. Moret, C. Cognard, A. I. Qureshi, A. S. Turk, A. Berenstein

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The proliferation of new endovascular devices and therapeutic strategies calls for a prudent and rational evaluation of their clinical benefit. This evaluation must be done in an effective manner and in collaboration with industry. Such research initiative requires organisational and methodological support to survive and thrive in a competitive environment. We propose the formation of an international consortium, an academic alliance committed to the pursuit of effective neurovascular therapies. Such a consortium would be dedicated to the design and execution of basic science, device development and clinical trials. The Consortium is owned and operated by its members. Members are international leaders in ineurointerventional research and clinical practice. The Consortium brings competency, knowledge, and expertise to industry as well as to its membership across a spectrum of research initiatives such as: expedited review of clinical trials, protocol development, surveys and systematic reviews; laboratory expertise and support for research design and grant applications to public agencies. Once objectives and protocols are approved, the Consortium provides a stable network of centers capable of timely realization of clinical trials or preclinical investigations in an optimal environment. The Consortium is a non-profit organization. The potential revenue generated from clientsponsored financial agreements will be re-directed to the academic and research objectives of the organization. The Consortium wishes to work in concert with industry, to support emerging trends in neurovascular therapeutic development. The Consortium is a realistic endeavour optimally structured to promote excellence through scientific appraisal of our treatments, and to accelerate technical progress while maximizing patients' safety and welfare.

Original languageEnglish (US)
Pages (from-to)203-208
Number of pages6
JournalInterventional Neuroradiology
Volume14
Issue number2
StatePublished - Jun 2008

Fingerprint

Industry
Clinical Trials
Clinical Protocols
Research
Nonprofit Organizations
Equipment and Supplies
Organized Financing
Therapeutics
Patient Safety
Research Design
Organizations
Surveys and Questionnaires

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Radiological and Ultrasound Technology

Cite this

Raymond, J., White, P., Kallmes, D. F., Spears, J., Marotta, T., Roy, D., ... Berenstein, A. (2008). ICONE: An International Consortium of Neuro Endovascular Centres. Interventional Neuroradiology, 14(2), 203-208.

ICONE : An International Consortium of Neuro Endovascular Centres. / Raymond, Jean; White, P.; Kallmes, David F; Spears, J.; Marotta, T.; Roy, D.; Guilbert, F.; Weill, A.; Nguyen, T.; Molyneux, A. J.; Cloft, H.; Cekirge, S.; Saatci, I.; Bracard, S.; Meder, J. F.; Moret, J.; Cognard, C.; Qureshi, A. I.; Turk, A. S.; Berenstein, A.

In: Interventional Neuroradiology, Vol. 14, No. 2, 06.2008, p. 203-208.

Research output: Contribution to journalArticle

Raymond, J, White, P, Kallmes, DF, Spears, J, Marotta, T, Roy, D, Guilbert, F, Weill, A, Nguyen, T, Molyneux, AJ, Cloft, H, Cekirge, S, Saatci, I, Bracard, S, Meder, JF, Moret, J, Cognard, C, Qureshi, AI, Turk, AS & Berenstein, A 2008, 'ICONE: An International Consortium of Neuro Endovascular Centres', Interventional Neuroradiology, vol. 14, no. 2, pp. 203-208.
Raymond J, White P, Kallmes DF, Spears J, Marotta T, Roy D et al. ICONE: An International Consortium of Neuro Endovascular Centres. Interventional Neuroradiology. 2008 Jun;14(2):203-208.
Raymond, Jean ; White, P. ; Kallmes, David F ; Spears, J. ; Marotta, T. ; Roy, D. ; Guilbert, F. ; Weill, A. ; Nguyen, T. ; Molyneux, A. J. ; Cloft, H. ; Cekirge, S. ; Saatci, I. ; Bracard, S. ; Meder, J. F. ; Moret, J. ; Cognard, C. ; Qureshi, A. I. ; Turk, A. S. ; Berenstein, A. / ICONE : An International Consortium of Neuro Endovascular Centres. In: Interventional Neuroradiology. 2008 ; Vol. 14, No. 2. pp. 203-208.
@article{70b4beab3a7f42528a3d831d67f0e733,
title = "ICONE: An International Consortium of Neuro Endovascular Centres",
abstract = "The proliferation of new endovascular devices and therapeutic strategies calls for a prudent and rational evaluation of their clinical benefit. This evaluation must be done in an effective manner and in collaboration with industry. Such research initiative requires organisational and methodological support to survive and thrive in a competitive environment. We propose the formation of an international consortium, an academic alliance committed to the pursuit of effective neurovascular therapies. Such a consortium would be dedicated to the design and execution of basic science, device development and clinical trials. The Consortium is owned and operated by its members. Members are international leaders in ineurointerventional research and clinical practice. The Consortium brings competency, knowledge, and expertise to industry as well as to its membership across a spectrum of research initiatives such as: expedited review of clinical trials, protocol development, surveys and systematic reviews; laboratory expertise and support for research design and grant applications to public agencies. Once objectives and protocols are approved, the Consortium provides a stable network of centers capable of timely realization of clinical trials or preclinical investigations in an optimal environment. The Consortium is a non-profit organization. The potential revenue generated from clientsponsored financial agreements will be re-directed to the academic and research objectives of the organization. The Consortium wishes to work in concert with industry, to support emerging trends in neurovascular therapeutic development. The Consortium is a realistic endeavour optimally structured to promote excellence through scientific appraisal of our treatments, and to accelerate technical progress while maximizing patients' safety and welfare.",
author = "Jean Raymond and P. White and Kallmes, {David F} and J. Spears and T. Marotta and D. Roy and F. Guilbert and A. Weill and T. Nguyen and Molyneux, {A. J.} and H. Cloft and S. Cekirge and I. Saatci and S. Bracard and Meder, {J. F.} and J. Moret and C. Cognard and Qureshi, {A. I.} and Turk, {A. S.} and A. Berenstein",
year = "2008",
month = "6",
language = "English (US)",
volume = "14",
pages = "203--208",
journal = "Interventional Neuroradiology",
issn = "1123-9344",
publisher = "Centauro srl",
number = "2",

}

TY - JOUR

T1 - ICONE

T2 - An International Consortium of Neuro Endovascular Centres

AU - Raymond, Jean

AU - White, P.

AU - Kallmes, David F

AU - Spears, J.

AU - Marotta, T.

AU - Roy, D.

AU - Guilbert, F.

AU - Weill, A.

AU - Nguyen, T.

AU - Molyneux, A. J.

AU - Cloft, H.

AU - Cekirge, S.

AU - Saatci, I.

AU - Bracard, S.

AU - Meder, J. F.

AU - Moret, J.

AU - Cognard, C.

AU - Qureshi, A. I.

AU - Turk, A. S.

AU - Berenstein, A.

PY - 2008/6

Y1 - 2008/6

N2 - The proliferation of new endovascular devices and therapeutic strategies calls for a prudent and rational evaluation of their clinical benefit. This evaluation must be done in an effective manner and in collaboration with industry. Such research initiative requires organisational and methodological support to survive and thrive in a competitive environment. We propose the formation of an international consortium, an academic alliance committed to the pursuit of effective neurovascular therapies. Such a consortium would be dedicated to the design and execution of basic science, device development and clinical trials. The Consortium is owned and operated by its members. Members are international leaders in ineurointerventional research and clinical practice. The Consortium brings competency, knowledge, and expertise to industry as well as to its membership across a spectrum of research initiatives such as: expedited review of clinical trials, protocol development, surveys and systematic reviews; laboratory expertise and support for research design and grant applications to public agencies. Once objectives and protocols are approved, the Consortium provides a stable network of centers capable of timely realization of clinical trials or preclinical investigations in an optimal environment. The Consortium is a non-profit organization. The potential revenue generated from clientsponsored financial agreements will be re-directed to the academic and research objectives of the organization. The Consortium wishes to work in concert with industry, to support emerging trends in neurovascular therapeutic development. The Consortium is a realistic endeavour optimally structured to promote excellence through scientific appraisal of our treatments, and to accelerate technical progress while maximizing patients' safety and welfare.

AB - The proliferation of new endovascular devices and therapeutic strategies calls for a prudent and rational evaluation of their clinical benefit. This evaluation must be done in an effective manner and in collaboration with industry. Such research initiative requires organisational and methodological support to survive and thrive in a competitive environment. We propose the formation of an international consortium, an academic alliance committed to the pursuit of effective neurovascular therapies. Such a consortium would be dedicated to the design and execution of basic science, device development and clinical trials. The Consortium is owned and operated by its members. Members are international leaders in ineurointerventional research and clinical practice. The Consortium brings competency, knowledge, and expertise to industry as well as to its membership across a spectrum of research initiatives such as: expedited review of clinical trials, protocol development, surveys and systematic reviews; laboratory expertise and support for research design and grant applications to public agencies. Once objectives and protocols are approved, the Consortium provides a stable network of centers capable of timely realization of clinical trials or preclinical investigations in an optimal environment. The Consortium is a non-profit organization. The potential revenue generated from clientsponsored financial agreements will be re-directed to the academic and research objectives of the organization. The Consortium wishes to work in concert with industry, to support emerging trends in neurovascular therapeutic development. The Consortium is a realistic endeavour optimally structured to promote excellence through scientific appraisal of our treatments, and to accelerate technical progress while maximizing patients' safety and welfare.

UR - http://www.scopus.com/inward/record.url?scp=48449092952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449092952&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:48449092952

VL - 14

SP - 203

EP - 208

JO - Interventional Neuroradiology

JF - Interventional Neuroradiology

SN - 1123-9344

IS - 2

ER -